Literature DB >> 23575760

Does early coronary artery bypass surgery improve survival in non-ST acute myocardial infarction?

Victor Dayan1, Gerardo Soca, Gabriel Parma, Rafael Mila.   

Abstract

A best evidence topic was written according to a structured protocol. Lack of evidence exists regarding the optimal timing for coronary artery bypass graft (CABG) surgery after non-ST myocardial infarction (NSTEMI). While some authors address the importance of the timing of surgery alone, others take into account the extent of myocardial damage. The question addressed was whether early or late CABG surgery improves hospital mortality and cardiovascular events after NSTEMI in stable patients. Using a designated search strategy, 459 articles were found, of which seven represented the best available evidence. All of these studies were level 3 (retrospective cohort studies). Studies could be divided into those which assessed CABG outcome based on preoperative cardiac troponin I (cTnI) level as a measure of the extent of myocardial damage and those which considered only the timing after myocardial infarction. Outcome measures included short-term survival, hospital mortality, length of hospital stay and major adverse cardiovascular events (MACEs). The biggest retrospective study analysing postoperative outcomes based on the timing of surgery after NSTEMI concluded that operative mortality is higher when surgery is performed within 6 h of the event. After 6 h, mortality is similar at any timepoint after 6h of NSTEMI. While other smaller studies agree that there are fewer postoperative complications when surgery is performed after 48 h of the event, no consensus is found regarding mortality between early (less than 48 h) and late CABG surgery. Taking into account preoperative cTnI values, CABG has a higher incidence of MACEs and hospital mortality in patients with cTnI >0.15 ng/ml. When surgery is performed within 24 h of symptoms, preoperative cTnI >0.72 ng/ml is associated with worse outcomes. In view of the methodological limitations and level of evidence of the studies included, it appears that surgery may be safely performed in NSTEMI patients at any time after the first 6 h of the event in patients with cTnI <0.15 ng/ml, whereas in those patients with higher values of cTnI, waiting for cTnI to reduce before considering surgery seems to be a wise option in order to decrease the incidence of MACEs and hospital mortality.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23575760      PMCID: PMC3686395          DOI: 10.1093/icvts/ivt128

Source DB:  PubMed          Journal:  Interact Cardiovasc Thorac Surg        ISSN: 1569-9285


  8 in total

1.  Preoperative cardiac troponin I to assess midterm risks of coronary bypass grafting operations in patients with recent myocardial infarction.

Authors:  Domenico Paparella; Giuseppe Scrascia; Andreas Paramythiotis; Pietro Guida; Vito Magari; Pietro Giorgio Malvindi; Stefano Favale; Luigi de Luca Tupputi Schinosa
Journal:  Ann Thorac Surg       Date:  2010-03       Impact factor: 4.330

2.  Towards evidence-based medicine in cardiothoracic surgery: best BETS.

Authors:  Joel Dunning; Brian Prendergast; Kevin Mackway-Jones
Journal:  Interact Cardiovasc Thorac Surg       Date:  2003-12

3.  Prognostic value of preoperative cardiac troponin I in patients with non-ST-segment elevation acute coronary syndromes undergoing coronary artery bypass surgery.

Authors:  Matthias Thielmann; Parwis Massoudy; Markus Neuhäuser; Stephan Knipp; Markus Kamler; Jarowit Piotrowski; Klaus Mann; Heinz Jakob
Journal:  Chest       Date:  2005-11       Impact factor: 9.410

4.  Appropriate timing of elective coronary artery bypass graft surgery following acute myocardial infarction.

Authors:  R K Deeik; T M Schmitt; T G Ihrig; J T Sugimoto
Journal:  Am J Surg       Date:  1998-12       Impact factor: 2.565

5.  Optimal timing of revascularization: transmural versus nontransmural acute myocardial infarction.

Authors:  D C Lee; M C Oz; A D Weinberg; S X Lin; W Ting
Journal:  Ann Thorac Surg       Date:  2001-04       Impact factor: 4.330

6.  Prognostic value of preoperative cardiac troponin I in patients undergoing emergency coronary artery bypass surgery with non-ST-elevation or ST-elevation acute coronary syndromes.

Authors:  Matthias Thielmann; Parwis Massoudy; Markus Neuhäuser; Konstantinos Tsagakis; Günter Marggraf; Markus Kamler; Klaus Mann; Raimund Erbel; Heinz Jakob
Journal:  Circulation       Date:  2006-07-04       Impact factor: 29.690

7.  Timing of in-hospital coronary artery bypass graft surgery for non-ST-segment elevation myocardial infarction patients results from the National Cardiovascular Data Registry ACTION Registry-GWTG (Acute Coronary Treatment and Intervention Outcomes Network Registry-Get With The Guidelines).

Authors:  Shailja V Parikh; James A de Lemos; Michael E Jessen; Emmanouil S Brilakis; E Magnus Ohman; Anita Y Chen; Tracy Y Wang; Eric D Peterson; Matthew T Roe; Elizabeth M Holper
Journal:  JACC Cardiovasc Interv       Date:  2010-04       Impact factor: 11.195

8.  Optimal timing of coronary artery bypass graft surgery after acute myocardial infarction.

Authors:  J H Braxton; G L Hammond; G V Letsou; K L Franco; G S Kopf; J A Elefteriades; J C Baldwin
Journal:  Circulation       Date:  1995-11-01       Impact factor: 29.690

  8 in total
  5 in total

1.  eComment. Troponin I, coronary artery bypass grafting and perioperative ischaemia.

Authors:  Andony J Baddour
Journal:  Interact Cardiovasc Thorac Surg       Date:  2013-07

2.  eComment. Early coronary artery bypass surgery for acute non-ST elevation myocardial infarction.

Authors:  Senol Yavuz; Cuneyt Eris
Journal:  Interact Cardiovasc Thorac Surg       Date:  2013-07

3.  eComment. Troponin I cut-off point is different based on the used assay.

Authors:  Omid Assar; Mohammadhasan Kalantarmotamedi; Davoud Kazemisaleh
Journal:  Interact Cardiovasc Thorac Surg       Date:  2013-07

4.  Revascularization following non-ST elevation myocardial infarction in multivessel coronary disease.

Authors:  Lauren V Huckaby; Ibrahim Sultan; Suresh Mulukutla; Dustin Kliner; Thomas G Gleason; Yisi Wang; Floyd Thoma; Arman Kilic
Journal:  J Card Surg       Date:  2020-05-03       Impact factor: 1.778

Review 5.  The Therapeutic Relevance of Urolithins, Intestinal Metabolites of Ellagitannin-Rich Food: A Systematic Review of In Vivo Studies.

Authors:  Wai-Kit Tow; Pui-Ying Chee; Usha Sundralingam; Uma Devi Palanisamy
Journal:  Nutrients       Date:  2022-08-25       Impact factor: 6.706

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.